Background Excessive daytime somnolence is a common report among patients who have
Parkinson disease (PD). The relative contributions of disease severity and of the various …

Sleep disturbances and daytime sleepiness are well‐known phenomena in Parkinson's
disease (PD). Fifteen previously untreated PD patients underwent clinical evaluation …

Excessive daytime somnolence (EDS) and quality of sleep were studied in 25 parkinsonian
patients at baseline, when they had not yet received any antiparkinsonian medication, and …

Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease. Its cardinal clinical features are bradykinesia, rigidity, tremor, and …

Study Objectives: Insomnia and daytime sleepiness are common complaints in Parkinson
disease (PD), but the main causes remain unclear. We examined the potential impact of …

Background Patients with Parkinson disease (PD) treated with the nonergot dopamine
agonists pramipexole dihydrochloride and ropinirole hydrochloride have been reported to …

Background Poor nocturnal sleep is common in Parkinson's disease (PD) and negatively
impacts quality of life. There is little data on how dopaminergic drugs influence nocturnal …

Measures of excessive daytime sleepiness, neuropsychologic function, and mood were
assessed in twenty-two persons with mid-stage Parkinson's disease (PD) and sixteen age …

Recent case reports of 'sleep attacks'(SA) in patients with Parkinson's disease (PD)
generated concerns about drug‐induced daytime somnolence in this population. However …

Parkinson's disease (PD) is associated with sleep complaints as excessive daytime
sleepiness (EDS) and several factors have been implicated in the genesis of these …